Earlier this year, urology resident Philip Cheng, M.D., appeared on the front page of The New York Times explaining his situation. Now, in a podcast, he tells Paul Sax, M.D., more about himself and the events surrounding his decision to go public....
Leading researchers and clinicians who influence best practices for conversations about the direct and indirect impact of HIV infection and treatment agree that communications regarding transmission must shift.
Researchers examining issues facing post-exposure prophylaxis (PEP) users found that 74% of study participants had at least one psychosocial issue, including depression and/or problematic drug or alcohol use.
Broad PrEP Access in Australia Reduces HIV Infections Even With Reduced Condom Use by People Not on PrEP
A controversial new study is wrongly driving prejudice against PrEP, according to Simon Collins.
An experimental vaccine regimen based on the structure of a vulnerable site on HIV elicited antibodies in mice, guinea pigs and monkeys that neutralize dozens of HIV strains from around the world.
A drug combination aimed at preventing transmission of HIV from a pregnant woman to her fetus likely does not increase the risk for preterm birth and early infant death, according to a re-analysis of two studies.
Rob Newells, executive director of the AIDS Project of the East Bay, gives his personal (U.S.-centered, black MSM-focused) highlights from CROI 2018.
After Greece experienced a large increase in the number of new HIV infections among people who inject drugs, organizations launched a program to "seek, test, treat, and retain" in order to put a halt to the outbreak.
Nearly 90 percent of participants in an open-label study of a vaginal ring infused with a drug to prevent HIV are using the monthly ring at least some of the time, according to data presented at CROI 2018.
A summary of key facts and statistics about HIV in correctional settings.